Keith Katkin - Director at Rigel Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RIGL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Keith Katkin since 11/9/2023

Holdings reported by Keith Katkin for Rigel Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 25K $43.8K $1.75 May 19, 2021 Direct
Stock Option (Right to Buy) 30K May 19, 2021 Direct Common Stock

Transactions reported by Keith Katkin for Rigel Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.